openPR Logo
Press release

Global 3D printed drugs market with significant market size of USD 1,559.8 Million by the end of 2024 from USD 489.9 Million in 2017 :Top Keyplayers are Aprecia Pharmaceuticals LLC., FabRx Ltd. and GlaxoSmithKline (GSK)

02-22-2019 10:22 PM CET | Industry, Real Estate & Construction

Press release from: Kenneth Research

Global 3D printed drugs market with significant market size

Market Trends in Global 3D Printed Drugs Market

In 2017, the Aprecia Pharmaceuticals LLC revealed that they signed a partnership contract with Cycle Pharmaceuticals Ltd. to improve and commercialize orphan drugs using three-dimensionally printed (“3DP”) technology.
FabRx invested in Sintratec Kit for Sintratec Selective Laser Sintering (SLS) 3D printed medicine that helped the company with the expansion of its product portfolio.

Request For Free Sample@ https://www.kennethresearch.com/sample-request-10076321

Market Overview

The technological revolution of 3D printing has changed the face of the medicine by contributing in numerous applications in the form of 3D printed drugs. The 3D Printed Drugs market is anticipated to witness lucrative growth in the near future. The ease of ingestion of the drugs for the patients suffering from several diseases causing seizures such as epilepsy and medicinal intake by old age and infants among others are the various factors that are believed to affect the growth of the 3D Printed Drugs market in upcoming years. Further, various flavors can be induced in the medicine negating the sour taste. Their applications in customized medicinal therapy are widening its area to various diseases such as cancer and others that could not be done before. The research treatments such as the 3D printing customization in shape of medicine utilizes in various forms of medical implant to hone the patient value and overall healthcare systems across the globe. These factors are anticipated to bolster the 3D printed drugs market with significant market size of USD 1,559.8 Million by the end of 2024 from USD 489.9 Million in 2017. Furthermore, the global 3D printed drugs market is predicted to witness robust growth by expanding at a CAGR of 18.2% over the period 2018-2024.

Growth Highlights based upon Regional Platform during 2017-2024

The global 3D printed drugs market is segmented by regions into North America, Latin America, Europe, Asia-Pacific and Middle East and Africa. Among these regions, the Asia-Pacific 3D printed drugs market accounted for the dominating market size of USD 166.3 Million in 2017 and is believed to grow with this positive growth over the forecast period, which can be attributed to the robust expansion of the pharmaceutical industries in this region. Further, rising adoption of advanced healthcare technologies by consumers on the back of swelled disposable income is expected to positively drive the growth of the market in this region.

With U.S. as the prominent region, the North America 3D printed drugs market is believed to hold the second largest market share in 2024 owing to the presence of well-established healthcare industry along with the expanded funding from the government organizations in the region. In addition to that, U.S. 3D printed drugs market is expected to achieve Y-o-Y growth rate of 20.4% in 2024 as compared to previous year.

Furthermore, the growth and expansion of the pharmaceutical industry along with the increasing applications of the 3D printed drugs is expected to fuel the growth of the Europe market of 3D printed drugs during the forecast period, where France and Germany are the major contributors behind the growth of the Europe 3D printed drugs market.

Buy Now@ https://www.kennethresearch.com/report-purchase-id-10076321

Market Segmentation Synopsis

By Application

The global 3D printed drugs market has been segmented by application into orthopedic, neurology, hearing & audibility aid, medical implants, dental and others. Among these segments, the neurology segment accounted for the dominating market share of more than 35% in the overall market of 3D printed drugs around the globe. More than 600 diseases related to brain disorders exists which are directly or indirectly related to the malfunctioning of the nervous system. Various applications in medical science in relation to 3D printed drugs could significantly affect the current medication system to bring positive results. Driven by these factors, the neurology segment is believed to dominate the 3D printed drugs market and is anticipated to achieve absolute $ opportunity of USD 437.9 Million between 2018 and 2024. The second largest segment in the 3D printed drugs market is orthopedic segment which held 23.0% of the total market share in 2016 and is predicted to observe significant growth rate over the period 2018-2024. Further, the hearing and audibility aid segment is estimated to expand with highest CAGR during the forecast year.

The study further analysis the Y-O-Y Growth, demand & supply and forecast future opportunity in North America (United States, Canada), Latin America (Brazil, Mexico, Argentina, Rest of LATAM), Europe (U.K., Germany, France, Italy, Spain, Hungary, BENELUX (Belgium, Netherlands, Luxembourg), NORDIC (Norway, Denmark, Sweden, Finland), Poland, Russia, Rest of Europe), Asia-Pacific (China, India, Japan, South Korea, Malaysia, Indonesia, Taiwan, Hong Kong, Australia, New Zealand, Rest of Asia-Pacific), Middle East and Africa (Israel, GCC (Saudi Arabia, UAE, Bahrain, Kuwait, Qatar, Oman), North Africa, South Africa, Rest of Middle East and Africa).

Market Drivers & Challenges

Growth Indicators

The global 3D printed drugs market is thriving on the back of high-drug loading capacity such as high production rates and increasing R&D activities among major market players and other small companies that are additionally driving the growth of the market. The increased spending on research and development activities is anticipated to increase the 3D printed drugs market share rapidly in the future. Further, the size, dose, appearance and rate of the delivery of a drug can be designed to suit an individual which will make it easier for the patients to take these medicines. In addition to that, the chewable formulations similar to gummies with a diverse range of shapes, sizes, colors, textures and flavors to make them more attractive to various patient groups, particularly the young or the elderly, facilitating compliance of the treatment is anticipated to propel the 3D printed drugs market in upcoming years.

Additionally, the increasing advancements in 3D printing technology to increase the product varieties as well as the personalization abilities is also believed to aid the 3D printed drugs market to grow in the near future.

Barriers

The regulatory norms associated with the approval for 3D printed drugs are very strict in the developed countries due to various security and safety reasons which are anticipated to slow down the adoption rate of 3D printed drugs. Moreover, drug companies involved in the 3D printed drugs market would need to ensure that the right packaging and user instructions are accessible which is otherwise difficult to achieve. These factors might inhibit the growth of the 3D printed drugs market around the globe.

Competitive Landscape

Some of the affluent industry leaders in the global 3D printed drugs market are Aprecia Pharmaceuticals LLC., FabRx Ltd. and GlaxoSmithKline (GSK).

GlaxoSmithKline (GSK), a British pharmaceutical company headquartered in Brentford, London, is the only well-established pharmaceutical firm to demonstrate an interest in exploring 3D printing technologies for its supply chain. The company’s fundamental strategy is based upon business collaborations that help it to work with partners to deliver new and innovative medicines, vaccines and consumer healthcare products.

Moreover, other key and niche players are working towards the expansion of product portfolio along with investing in high quality R&D to develop healthcare products in order to gain competitive edge in the global 3D printed drugs market.

Read More@ https://www.kennethresearch.com/report-details/3d-printed-drugs-market/10076321

About Kenneth Research

Kenneth Research is a reselling agency providing market research solutions in different verticals such as Automotive and Transportation, Chemicals and Materials, Healthcare, Food & Beverage and Consumer Packaged Goods, Semiconductors, Electronics & ICT, Packaging, and Others. Our portfolio includes set of market research insights such as market sizing and market forecasting, market share analysis and key positioning of the players (manufacturers, deals and distributors, etc), understanding the competitive landscape and their business at a ground level and many more. Our research experts deliver the offerings efficiently and effectively within a stipulated time. The market study provided by Kenneth Research helps the Industry veterans/investors to think and to act wisely in their overall strategy formulation

Contact Us

1412 Broadway,
21st Floor Suite MA111,
New York, NY 10018

Name:David
Email:sales@kennethresearch.com
Phone: +1 313 462 0609

This release was published on openPR.

Permanent link to this press release:

Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.

You can edit or delete your press release Global 3D printed drugs market with significant market size of USD 1,559.8 Million by the end of 2024 from USD 489.9 Million in 2017 :Top Keyplayers are Aprecia Pharmaceuticals LLC., FabRx Ltd. and GlaxoSmithKline (GSK) here

News-ID: 1611476 • Views:

More Releases from Kenneth Research

Global Cardiovascular Pharmaceuticals Market to be Propelled by Growing Investment in Research and Drug Development, and Increasing Prevalence of Heart Failure by CAGR of 5% During 2023- 2033
Global Cardiovascular Pharmaceuticals Market to be Propelled by Growing Investme …
Kenneth Research published a report titled "Cardiovascular Pharmaceuticals Market: Global Demand Analysis & Opportunity Outlook 2033" which delivers detailed overview of the global cardiovascular pharmaceuticals market in terms of market segmentation by drug class, distribution channel, indication and by region. Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that are associated with
Global Family Office Market to be Propelled by Surging Number of New Businesses by CAGR of ~5% During 2022 - 2031
Global Family Office Market to be Propelled by Surging Number of New Businesses …
Kenneth Research published a report titled "Family Office Market: Global Demand Analysis & Opportunity Outlook 2031" which delivers detailed overview of the global family office market in terms of market segmentation by services, type, net worth managed, and by region. Access Full Description: https://www.kennethresearch.com/report-details/family-office-market/10346745 Further, for the in-depth analysis, the report encompasses the industry growth indicators, restraints, supply and demand risk, along with detailed discussion on current and future market trends that
Photomask Market Growth Analysis by Revenue, Size, Share, Scenario on Latest Tre …
Kenneth Research provides an extensive study by our analysts which offers forecast assessment by correlating the historical data with key market dynamics. The Photomask Market further includes trends and opportunities that are highlighted, along with the market valuation. The market is segmented by segments and portrays the industry overview along with elaborate description of the market for the forecast period 2020-2025. The report also constitutes future growth statistics which is
Embedded Systems Market 2020 New Innovations Trends, Research, Global Share and …
Kenneth Research provides an extensive study by our analysts which offers forecast assessment by correlating the historical data with key market dynamics. The Embedded Systems Market further includes trends and opportunities that are highlighted, along with the market valuation. The market is segmented by segments and portrays the industry overview along with elaborate description of the market for the forecast period 2020-2025. The report also constitutes future growth statistics which

All 5 Releases


More Releases for America

Waterproof Labels Market Outlook, Supportive Judgments | SATO America, LANGGUTH …
Report Ocean recently published a new report on the Global Waterproof Labels Market. The study has an in-depth analysis of the forecast period from 2021-2025. The report reveals a comprehensive picture of the Waterproof Labels Market situation, taking into consideration all major trends, market dynamics, and competitive factors. Additionally, the report contains key statistics concerning the Waterproof Labels Market situation of the leading key players, key market trends, and potential
Textiles Market Analysis Report, Regional Outlook - Europe, North America, South …
Adroit Market Research has announced the addition of the “Global Textiles Market Size Status and Forecast 2025”, The report classifies the global Textiles in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth. This report studies the global Textiles Speaker market, analyzes and researches the Textiles Speaker development status and forecast in Europe, North America, Central America, South America, Asia Pacific
Blow Molding Machinery Market Analysis Report, Regional Outlook - Europe, North …
Adroit Market Research has announced the addition of the “Global Blow Molding Machinery Market Size Status and Forecast 2025”, The report classifies the global Blow Molding Machinery in a precise manner to offer detailed insights about the aspects responsible for augmenting as well as restraining market growth. This report studies the global Blow Molding Machinery Speaker market, analyzes and researches the Blow Molding Machinery Speaker development status and forecast in Europe,
Global Gaucher Disease Market 2018 Covering North America, South America, Europe
Gaucher Disease Market Summary The Global Gaucher Disease Market is defined by the presence of some of the leading competitors operating in the market, including the well-established players and new entrants, and the suppliers, vendors, and distributors. The key players are continuously focusing on expanding their geographic reach and broadening their customer base, in order to expand their product portfolio and come up with new advancements. Gaucher Disease market size to maintain the average annual growth
Epigenetics Market by End Users, and by Geography North America, Latin America, …
Increasing research to study the epigenetics of the genome (study called epigenomics) is expected to boost growth of the epigenetics market over the forecast period. Genome-wide epigenetic studies play an important role in the diagnostics of human diseases. Moreover, implementation of epigenetics for oncology research is estimated to propel the growth of epigenetics market. For instance, Constellation Pharmaceuticals, in April 2018, invested US$ 100 million for development of cancer epigenetics
Spas and Beauty Salons Market - South America, Central America and North America …
Consumers’ changing perception towards personal care coupled with continuous strive to improve general well-being are generating a positive impact on the spas and beauty salons industry. Growing consumer need to improve personal appearance and well-being has increased the demand for wellness solutions. Spa centers and beauty salons, in order to meet the increasing demand for unique spa and beauty services, are constantly striving to improve their services by focusing on